Abstract:Methyltransferase METTL3‐mediated maturation of miR‐4654 promotes high glucose‐induced apoptosis, oxidative stress, and viability inhibition in lens epithelial cells via decreasing SOD2. N6‐methyladenosine (m6A) modification has been reported to have roles in modulating the development of diabetic cataract (DC). Methyltransferase‐like 3 (METTL3) is a critical m6A methyltransferase involving in m6A modification activation. Here, we aimed to explore the action and mechanism of METTL3‐mediated maturation of miR‐4654 in DC progression. Human lens epithelial cells (HLECs) were exposed to high glucose (HG) to imitate DC condition in vitro. Levels of genes and proteins were tested via qRT‐PCR and western blotting assays. The proliferation and apoptosis of HLECs were evaluated by cell counting kit‐8, 5‐ethynyl‐2′‐deoxyuridine (EdU), and flow cytometry assays, respectively. Oxidative stress was analyzed by detecting the contents of reactive oxygen species (ROS), superoxide dismutase (SOD) and malondialdehyde (MDA). The binding of miR‐4654 and SOD2 was confirmed by dual‐luciferase reporter assay. The m6A‐RNA immunoprecipitation (MeRIP) assay detected the m6A modification profile. Thereafter, we found that miR‐4654 expression was elevated in DC samples and HG‐induced HLECs. MiR‐4654 knockdown reversed HG‐mediated apoptosis and oxidative stress in HLECs. Mechanistically, miR‐4654 directly targeted SOD2, silencing of SOD2 abolished the protective effects of miR‐4654 knockdown on HLECs under HG condition. In addition, METTL3 induced miR‐4654 maturation through promoting pri‐miR‐4654 m6A modification, thereby increasing miR‐4654 content in HLECs. METTL3 was highly expressed in DC samples and HG‐induced HLECs, METTL3 deficiency protected HLECs against HG‐mediated apoptotic and oxidative injury via down‐regulating miR‐4654. In all, METTL3 induced miR‐4654 maturation in a m6A‐dependent manner, which was then reduced SOD2 expression, thus promoting apoptosis and oxidative stress in HLECs, suggesting a novel path for DC therapy.

N<SUP>6</SUP>-Methyladenosine METTL3 Modulates the Proliferation and Apoptosis of Lens Epithelial Cells in Diabetic Cataract

METTL3-mediated m6A modification of SIRT1 mRNA affects the progression of diabetic cataracts through cellular autophagy and senescence

Methyltransferase METTL3‐mediated maturation of miR‐4654 facilitates high glucose‐induced apoptosis and oxidative stress in lens epithelial cells via decreasing SOD2

Analysis of N6-methyladenosine-modified mRNAs in diabetic cataract

Methyltransferase-like 3 Promotes Cervical Cancer Metastasis by Enhancing Cathepsin L Mrna Stability in an N6-methyladenosine-dependent Manner

Abstract 4827: N6-Methyladenosine Modification of LINC00901 Promotes Pancreatic Cancer Progression

Retraction Note: RNA M6a Methylation Regulates the Epithelial Mesenchymal Transition of Cancer Cells and Translation of Snail.

N6‐Methyladenosine Regulates Cilia Elongation in Cancer Cells by Modulating HDAC6 Expression

METTL3's role in cervical cancer development through m6A modification

N6-methyladenosine METTL3 promotes cervical cancer tumorigenesis and Warburg effect through YTHDF1/HK2 modification

METTL3-mediated <i>N</i><SUP>6</SUP>-methyladenosine modification governs pericyte dysfunction during diabetes-induced retinal vascular complication

N<SUP>6</SUP>-methyladenosine as a biological and clinical determinant in colorectal cancer: progression and future direction

METTL3-mediated N 6 -methyladenosine modification governs pericyte dysfunction during diabetes-induced retinal vascular complication

METTL3-mediated N6-methyladenosine Modification is Critical for Epithelial-Mesenchymal Transition and Metastasis of Gastric Cancer.

Changes in N6-Methyladenosine Modification Modulate Diabetic Cardiomyopathy by Reducing Myocardial Fibrosis and Myocyte Hypertrophy

Alteration of N6-methyladenosine epitranscriptome profile in lipopolysaccharide-induced mouse mesangial cells

Role of METTL3-Dependent N6-Methyladenosine mRNA Modification in the Promotion of Angiogenesis

N6-Methyladenosine Regulates the Expression and Secretion of TGFβ1 to Affect the Epithelial–Mesenchymal Transition of Cancer Cells

METTL3-Mediated N6-methyladenosine mRNA Modification and cGAS-STING Pathway Activity in Kidney Fibrosis

METTL3-mediated M6a Modification of TIMP2 Mrna Promotes Podocyte Injury in Diabetic Nephropathy

WTAP and METTL14 Regulate the M6a Modification of DKK3 in Renal Tubular Epithelial Cells of Diabetic Nephropathy